Dual-phase 18F-FDG PET can predict lung adenocarcinoma outcome

03/31/2010 | HealthImaging.com

A study involving patients with histologically confirmed lung adenocarcinoma found that the change in maximal standardized uptake values between early and delayed 18F-FDG PET can be a strong singular predictor of patient outcome and aid in patient management. "Patients with more than 25 percent increase in SUVmax had a median survival of 15 months, compared with 39 months for those with less than 25 percent increase in SUVmax," the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ